000			02100 a2200613 4500
005			20250518023454.0
264		0	_c20200504
008			202005s 0 0 eng d
022			_a1365-2141
024	7		_a10.1111/bjh.15790 _2doi
040			_aNLM _beng _cNLM
100	1		_aSocié, Gérard
245	0	0	_aEculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10-year pharmacovigilance analysis. _h[electronic resource]
260			_bBritish journal of haematology _c04 2019
300			_a297-310 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xadverse effects
650	0	4	_aAtypical Hemolytic Uremic Syndrome _xdrug therapy
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aComplement Inactivating Agents _xadverse effects
650	0	4	_aDatabases, Factual
650	0	4	_aFatigue _xchemically induced
650	0	4	_aFemale
650	0	4	_aFever _xchemically induced
650	0	4	_aHemoglobins _xdeficiency
650	0	4	_aHemoglobinuria, Paroxysmal _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aMeningococcal Infections _xchemically induced
650	0	4	_aMiddle Aged
650	0	4	_aOpportunistic Infections _xchemically induced
650	0	4	_aPharmacovigilance
650	0	4	_aPregnancy
650	0	4	_aPregnancy Complications _xdrug therapy
650	0	4	_aPregnancy Outcome
650	0	4	_aYoung Adult
700	1		_aCaby-Tosi, Marie-Pierre
700	1		_aMarantz, Jing L
700	1		_aCole, Alexander
700	1		_aBedrosian, Camille L
700	1		_aGasteyger, Christoph
700	1		_aMujeebuddin, Arshad
700	1		_aHillmen, Peter
700	1		_aVande Walle, Johan
700	1		_aHaller, Hermann
773	0		_tBritish journal of haematology _gvol. 185 _gno. 2 _gp. 297-310
856	4	0	_uhttps://doi.org/10.1111/bjh.15790 _zAvailable from publisher's website
999			_c29377059 _d29377059